1AO3 | A:1-187; B:1-187 | A3 DOMAIN OF VON WILLEBRAND FACTOR |
1AOX | A:139-339; B:137-337 | I DOMAIN FROM INTEGRIN ALPHA2-BETA1 |
1ATZ | B:922-1110; A:925-1108 | HUMAN VON WILLEBRAND FACTOR A3 DOMAIN |
1AUQ | A:498-705 | A1 DOMAIN OF VON WILLEBRAND FACTOR |
1BHO | 1:133-321; 2:433-621 | MAC-1 I DOMAIN MAGNESIUM COMPLEX |
1BHQ | 1:133-321; 2:433-621 | MAC-1 I DOMAIN CADMIUM COMPLEX |
1CQP | A:128-309; B:128-309 | CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION |
1DGQ | A:124-311 | NMR SOLUTION STRUCTURE OF THE INSERTED DOMAIN OF HUMAN LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1 |
1FE8 | C:920-1110; A:921-1110; B:921-1110 | CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING |
1IDN | 1:133-321; 2:433-621 | MAC-1 I DOMAIN METAL FREE |
1IDO | A:132-315 | I-DOMAIN FROM INTEGRIN CR3, MG2+ BOUND |
1IJB | A:500-701 | THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN |
1IJK | A:502-700 | THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN-BOTROCETIN COMPLEX |
1JEQ | A:35-250; B:6-242 | CRYSTAL STRUCTURE OF THE KU HETERODIMER |
1JLM | A:132-318 | I-DOMAIN FROM INTEGRIN CR3, MN2+ BOUND |
1JV2 | B:109-352 | CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3 |
1L5G | B:109-352 | CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGAND |
1LFA | A:128-310; B:128-309 | CD11A I-DOMAIN WITH BOUND MN++ |
1M10 | A:505-703 | CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB ALPHA AND THE VON WILLEBRAND FACTOR A1 DOMAIN |
1M1U | A:132-315 | AN ISOLEUCINE-BASED ALLOSTERIC SWITCH CONTROLS AFFINITY AND SHAPE SHIFTING IN INTEGRIN CD11B A-DOMAIN |
1M1X | B:109-352 | CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+ |
1MF7 | A:128-321 | INTEGRIN ALPHA M I DOMAIN |
1MQ8 | B:130-306; D:130-306 | CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1 |
1MQ9 | A:128-300 | CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN WITH LIGAND MIMETIC CRYSTAL CONTACT |
1MQA | A:127-300 | CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN IN THE ABSENCE OF LIGAND OR METAL |
1N3Y | A:129-317 | CRYSTAL STRUCTURE OF THE ALPHA-X BETA2 INTEGRIN I DOMAIN |
1N9Z | A:132-315 | INTEGRIN ALPHA M I DOMAIN MUTANT |
1NA5 | A:130-324 | INTEGRIN ALPHA M I DOMAIN |
1PT6 | B:143-337; A:142-333 | I DOMAIN FROM HUMAN INTEGRIN ALPHA1-BETA1 |
1Q0P | A:243-451 | A DOMAIN OF FACTOR B |
1QC5 | A:30-221; B:332-521 | I DOMAIN FROM INTEGRIN ALPHA1-BETA1 |
1QCY | A:141-333 | THE CRYSTAL STRUCTURE OF THE I-DOMAIN OF HUMAN INTEGRIN ALPHA1BETA1 |
1RD4 | A:128-311; B:128-311; C:128-311; D:128-311 | AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN |
1RRK | A:243-451 | CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B |
1RS0 | A:243-451 | CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH DI-ISOPROPYL-PHOSPHATE (DIP) |
1RTK | A:243-451 | CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH 4-GUANIDINOBENZOIC ACID |
1SHT | X:41-217 | CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR |
1SHU | X:38-218 | CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR |
1SQ0 | A:506-703 | CRYSTAL STRUCTURE OF THE COMPLEX OF THE WILD-TYPE VON WILLEBRAND FACTOR A1 DOMAIN AND GLYCOPROTEIN IB ALPHA AT 2.6 ANGSTROM RESOLUTION |
1T0P | A:127-300 | STRUCTURAL BASIS OF ICAM RECOGNITION BY INTEGRIN ALPAHLBETA2 REVEALED IN THE COMPLEX STRUCTURE OF BINDING DOMAINS OF ICAM-3 AND ALPHALBETA2 AT 1.65 A |
1TYE | B:107-353; D:107-353; F:107-353 | STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND-MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN |
1U0N | A:498-705 | THE TERNARY VON WILLEBRAND FACTOR A1-GLYCOPROTEIN IBALPHA-BOTROCETIN COMPLEX |
1U8C | B:1109-1352 | A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE |
1XDD | A:128-309; B:128-309 | X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION |
1XDG | A:128-309; B:128-309 | X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION |
1XUO | A:128-308; B:128-302 | X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 1,4-DIAZEPANE-2,5-DIONE INHIBITOR AT 1.8A RESOLUTION |
1ZON | A:128-308 | CD11A I-DOMAIN WITHOUT BOUND CATION |
1ZOO | A:128-310; B:128-310 | CD11A I-DOMAIN WITH BOUND MAGNESIUM ION |
1ZOP | A:128-310; B:128-310 | CD11A I-DOMAIN WITH BOUND MAGNESIUM ION |
2ADF | A:922-1110 | CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3, AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN |
2ICA | A:128-306 | CD11A (LFA1) I-DOMAIN COMPLEXED WITH BMS-587101 AKA 5-[(5S, 9R)-9-(4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1-METHYL-2,4-DIOXO-1,3,7-TRIAZASPIRO [4.4]NON-7-YL]METHYL]-3-THIOPHENECARBOXYLICACID |
2NUP | A:127-399 | CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER, COMPLEXED WITH THE SNARE PROTEIN SEC22B |
2NUT | A:127-399 | CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER, COMPLEXED WITH THE SNARE PROTEIN SEC22B |
2O7N | A:128-307 | CD11A (LFA1) I-DOMAIN COMPLEXED WITH 7A-[(4-CYANOPHENYL) METHYL]-6-(3,5-DICHLOROPHENYL)-5-OXO-2,3,5,7A-TETRAHYDRO-1H-PYRROLO[1,2-A]PYRROLE-7-CARBONITRILE |
3BN3 | A:128-307 | CRYSTAL STRUCTURE OF ICAM-5 IN COMPLEX WITH AL I DOMAIN |
3BQM | B:128-309; C:128-309 | LFA-1 I DOMAIN BOUND TO INHIBITORS |
3BQN | B:128-309; C:128-309 | LFA-1 I DOMAIN BOUND TO INHIBITORS |
3E2M | A:128-309; B:128-309 | LFA-1 I DOMAIN BOUND TO INHIBITORS |
3EFO | A:127-399 | CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF SYNTAXIN 5 |
3EG9 | A:127-399 | CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF MEMBRIN |
3EGD | A:127-399 | CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22 AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF VESICULAR STOMATITIS VIRUS GLYCOPROTEIN |
3EGX | A:127-399 | CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22B AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF THE SNARE PROTEIN BET1 |
3F74 | A:128-307; B:128-307; C:128-307 | CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN |
3F78 | A:128-307; B:128-307; C:128-307 | CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE |
3HI6 | A:128-307; B:128-307 | CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57 |
3HXO | A:507-705 | CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172, AN INHIBITOR OF VWF-PLATELET BINDING |